Diadema Partners’s Shattuck Labs STTK Stock Holding History

Diadema Partners’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-293,664	Closed	-$1.89M	–	193
2026 Q1	$1.89M	Buy	+293,664	New	+$1.39M	0.32%	64

Other funds holding STTK

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

NCM

NEXTBio Capital Management Menlo Park, California $217M AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Diadema Partners's STTK Position: Q2 2026 in Review

Diadema Partners sold out of Shattuck Labs (STTK) in Q2 2026, closing a stake of 293,664 shares — an estimated $1.89M sold.

Diadema Partners first reported a position in STTK in Q1 2026 and held it in 1 quarter. The position peaked at $1.89M in Q1 2026. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

Diadema Partners reported no remaining Shattuck Labs position as of Q2 2026 after selling out during the quarter.
Diadema Partners sold 293,664 Shattuck Labs shares in Q2 2026, an estimated $1.89M.
Diadema Partners first reported a position in Shattuck Labs in Q1 2026 and held it in 1 quarter.
Diadema Partners's Shattuck Labs position peaked at $1.89M in Q1 2026.
100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.